Navigation Links
Quidel and Abbott Lead in Market for POC Cardiac Markers: Kalorama Report
Date:7/17/2019

Quidel is the market leader in point-of-care (POC) cardiac markers, according to a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the top companies. The findings were reported in Kalorama Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics.

Quidel is a market leader in rapid immunoassays and has significant exposure to the POC markets relative to its size and total revenue, according to the report. Quidel acquired the assets of the Triage business from Alere when Alere was acquired by Abbott in October 2017. The panel combines troponin I, CK-MB, myoglobin, B-type natriuretic peptide (BNP), and D-dimer to provide accurate results in whole blood and plasma. Quidel’s first products were dipstick pregnancy tests launched in 1984. Moving from its primary markets in rapid test kits, Quidel has in recent years introduced POC immunoanalyzers and rapid molecular tests to market.

Abbott with its i-STAT system is a leading provider of handheld cardiac marker tests. Siemens Healthineers and Roche compete in the market as well. Response Biomedical is a small company that develops, manufactures, and markets rapid on-site diagnostic tests for use with its RAMP system for clinical and environmental applications. The RAMP system consists of a portable fluorescent reader and single-use, disposable test cartridges.

Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point of care. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments, including the workplace, home, disaster care, and, most recently, convenience clinics.

The menu for POC continues to expand. In the past five to 10 years, POC products were developed in the following categories: HbA1c, BNP, whole-blood lactate, D-dimer, and C-reactive protein (CRP).

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and the CE Mark for POC or self-use. At the same time, more decentralized test venues invest in nonwaived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation, or an electronic medical record.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.

Read the full story at https://www.prweb.com/releases/quidel_and_abbott_lead_in_market_for_poc_cardiac_markers_kalorama_report/prweb16440579.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Report: Abbott Grows by Holding On to Core
2. Genetic Testing Market Outlook 2015-2020: Key Vendors Influencing the Industry Include Abbott, Roche, Siemens, Illumina, Thermo Fischer Scientific, and Myriad Genetics
3. Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers
4. Global Molecular Diagnostics Market 2016: Latest Instrumentation and Strategic Profiles of Leading Suppliers - Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan & Trinity Biotech
5. QualTex brings health care industry vet on board as COO: Ward Carter has held various roles at Abbott Laboratories
6. European Commission Clears Abbott Acquisition of Alere
7. S&D Marketing Advertising Awarded WBENC Certification
8. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
9. Bioengineered Skin Substitutes to 2016. Products, Players, Markets and Growth Prospects
10. Probiotic Action Announces Probiotics Lead the Digestive Health Market
11. Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... ... July 22, 2019 , ... While today Visikol is primarily ... of 3D tissue imaging , digital pathology , 3D cell ... 2013 as a products company. These products are focused on addressing the limitations ...
(Date:7/17/2019)... ... July 15, 2019 , ... CRISPR is often thought of ... trait can be removed, replaced, or edited, but Yiping Qi, assistant professor in Plant ... traditional applications in his latest publication in Nature Plants. In this comprehensive review, Qi ...
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent stem ... to eight military Veterans under the R3 Heroes Program. The Veterans included individuals and ... Heroes Program allow anyone to nominate a military Veteran, teacher or first responder to ...
(Date:7/2/2019)... (PRWEB) , ... July 02, 2019 , ... Leading Regenerative ... entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on regenerative veterinary ... animals. Animal Pharm was recently included in the Brentwood and Pacific ...
Breaking Biology Technology:
(Date:8/15/2019)... ... , ... Serialization deadlines in the US and European Union ... becomes fully applied in the United States in 2023, pharmaceutical companies are scrutinizing ... most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal system capabilities. ...
(Date:8/14/2019)... , ... August 14, 2019 , ... Join Jonathan Riek, ... session on Tuesday, September 10, 2019 at 1pm EDT to learn about two ... effective management. , NAFLD is the most common diffuse liver disease, with a ...
(Date:8/14/2019)... ... 2019 , ... Dr. Julie Reck of Veterinary Medical Center of Fort Mill has ... stem cell patient, her own geriatric Australian Shepherd, Simon, was treated in June 2019 for ... play but his body was weak, and he struggled to play fetch and other games ...
Breaking Biology News(10 mins):